Pharmacological Properties ofN-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-N′-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine Methanesulfonate (552-02), a Novel Epithelial Sodium Channel Blocker with Potential Clinical Efficacy for Cystic Fibrosis Lung Disease
2008 ◽
Vol 325
(1)
◽
pp. 77-88
◽
2018 ◽
Vol 22
(8)
◽
pp. 687-701
◽
2013 ◽
Vol 591
(18)
◽
pp. 4377-4387
◽
Keyword(s):
Keyword(s):
2014 ◽
Vol 11
(1)
◽
pp. 63-72
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2012 ◽
Vol 185
(8)
◽
pp. 862-873
◽
Keyword(s):